Learn how you could participate in a research study of an investigational drug for reducing the frequency of respiratory tract infections.
Are you at risk of developing a respiratory tract infection?
The results of this study will provide more information about the investigational drug and whether it could help prevent RTIs.
Who is eligible to participate in this study?
To pre-qualify for this study, you must be: 65 years of age or older and NOT have any of the following:
- Type 1 diabetes mellitus
- Chronic heart failure
- Autoimmune disease, such as rheumatoid arthritis
- Current smoker
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.
What will happen during this study?
If you are eligible for this study and you agree to participate, you will be randomly assigned (like flipping a coin) to receive either the investigational drug or placebo (like a sugar pill). You have an equal chance of receiving either one.
You will take your assigned study drug once a day for 16 weeks. Your total study participation will last about 6 months, which includes approximately 10 visits to the research office for tests and evaluations. There may be more visits required if you have a respiratory tract infection. There will be a follow up phone call about 1 year after you start in the study to ask some questions about your health.
What are the benefits and risks related to this study?
While you could benefit from participating in this study, that cannot be guaranteed. However, your participation may help elderly people in the future.
It is also possible you could experience a side effect during this study. Before you join the study, the study staff will review the full list of known risks and side effects with you.
Because research studies can affect the health of participants, you will be monitored closely while you are in this study. The sponsor of this study was required to design a protocol, which explains all study procedures in detail. An independent review board responsible for participant safety reviewed this protocol and requires that it be followed exactly.
If you would like to learn more about this study, please contact the study team via our application form.